Nektar Therapeutics
NKTR
NKTR
233 hedge funds and large institutions have $3.39B invested in Nektar Therapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 83
24% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 34
Holders
233
Holding in Top 10
–
Calls
$9.18M
Puts
$8.48M
Top Buyers
| 1 | +$33.2M | |
| 2 | +$20M | |
| 3 | +$13M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.82M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$7.63M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$22.3M | |
| 3 | -$15.9M | |
| 4 |
D.E. Shaw & Co
New York
|
-$11.4M |
| 5 |
Goldman Sachs
New York
|
-$11.4M |